Indications
Quadramet is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium [99mTc]-labelled biphosphonates on bone scan. The presence of osteoblastic metastases which take up technetium [99mTc]-labelled biphosphonates should be confirmed prior to therapy.
Composition
- Active substance
- samarium (153Sm) lexidronam pentasodium
- International name (INN)
- samarium [153Sm] lexidronam pentasodium
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Quadramet
- Active substance
- samarium (153Sm) lexidronam pentasodium
- ATC code
- V10BX02
- Group
- Various
- Therapeutic area
- Pain, Cancer